GLP-1 - CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS

• 1. 用于医学用途的稳定、延长的GLP-1/胰高血糖素受体共激动剂 [P] . 中国专利： CN105307672B . 2021.01.05
• 2. 胰高血糖素和GLP-1受体的长效共激动剂 [P] . 中国专利： CN111132690A . 2020-05-08
• 3. GLP-1 - CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS [P] . 韩国专利： KR20170073638A . 2017-06-28

  机译： GLP-1-葡聚糖和GLP-1受体的共激动剂

• 4. STABLE GLP-1 BASED GLP-1/GLUCAGON RECEPTOR CO-AGONISTS [P] . 欧洲知识产权局专利： EP3204408B1 . 2020-05-06

  机译： 稳定的基于GLP-1的GLP-1 /葡聚糖受体协同剂

• 5. /GLP-1 -GLUCAGON/GLP-1 RECEPTOR CO-AGONISTS [P] . 韩国专利： KR101972617B1 . 2019-04-25

  机译： / GLP-1 -GLUCAGON / GLP-1受体协同剂

• 1. A Functional Inhibitory Role of Habenular Glucagon-Like Peptide-1 (GLP-1) in Forebrain Reward Signaling [J] . Max Johnson, Alev M. Brigande, Jiahe Yue, 行为与脑科学期刊（英文） . 2021,第009期
• 2. Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality? [J] . Maryna V. Basalay, Sean M. Davidson, Derek M. Yellon 中国神经再生研究（英文版） . 2020,第010期
• 3. Vasodilator Effect of Glucagon: Receptorial Crosstalk Among Glucagon, GLP-1, and Receptor for Glucagon and GLP-1 [J] . Selley E., Kun S., Szijarto I. A., Hormone and Metabolic Research . 2016,第7期
• 4. Vasodilator Effect of Glucagon: Receptorial Crosstalk Among Glucagon, GLP-1, and Receptor for Glucagon and GLP-1 [J] . Selley E., Kun S., Szijarto I. A., Hormone and Metabolic Research . 2016,第7期
• 5. A Novel Glucagon-like Peptide-1 (GLP-1)/Glucagon Hybrid Peptide with Triple-acting Agonist Activity at Glucose-dependent Insulinotropic Polypeptide, GLP-1, and Glucagon Receptors and Therapeutic Potential in High Fat-fed Mice [J] . Victor Gault, Vikas Bhat, Nigel Irwin, The Journal of biological chemistry . 2013,第49期
• 6. Discovery and Structural Optimization of High Affinity Co-Agonists at the Glucagon and GLP-1 Receptors [C] . Tao Ma, Jonathan Day, Vasily Gelfanov American Peptide Symposium . 2009
• 7. Selective GLP-1 receptor antagonists and glucagon/GLP-1 co-agonists discovered through an investigation into the structure-activity relationship in glucagon-related peptides. [D] . Patterson, James T. 2011
• 8. Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD [O] . Marta Seghieri, Alexander S. Christensen, Andreas Andersen, 2018
• 9. Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor. [O] . Naichang Li, Jing Lu, Gary B Willars 2012

• 1. Efficacy and Safety of Basal-Supported Prandial GLP-1 Receptor Agonist Therapy [J] . Taichi Nagahisa ,Mitsuhisa Tabata ,Satoru Yamada . 糖尿病（英文） . 2017,第3期
• 2. Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus [J] . Vishal J Patel ,Amit A Joharapurkar ,Samadhan G Kshirsagar . 世界糖尿病杂志：英文版（电子版） . 2018,第6期
• 3. 迷走神经复合体注射GLP-1对糖尿病大鼠下丘脑GLP-1受体表达及胃排空的影响 [J] . 吕丰香 ,魏良洲 ,田字彬 . 胃肠病学和肝病学杂志 . 2013,第004期
• 4. GLP-1受体激动剂利拉鲁肽对糖皮质激素性骨质疏松大鼠的疗效和作用机制研究 [C] . 杨丽娜 ,杨靖 ,李娜 . 第十一次全国中西医结合内分泌代谢病学术大会暨糖尿病、甲状腺疾病防治高峰论坛 . 2018
• 5. 新型长效GLP-1受体激动剂抗糖尿病作用的实验研究 [A] . 王颖颖 . 2020